Provided by Tiger Trade Technology Pte. Ltd.

Scinai Immunotherapeutics Ltd.

1.42
+0.01000.71%
Pre-market: 1.430.0100+0.70%08:44 EDT
Volume:80.13K
Turnover:108.64K
Market Cap:1.92M
PE:-0.29
High:1.42
Open:1.36
Low:1.32
Close:1.41
52wk High:16.30
52wk Low:1.32
Shares:1.35M
Float Shares:1.27M
Volume Ratio:0.41
T/O Rate:6.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8918
EPS(LYR):59.48
ROE:-26.53%
ROA:-36.15%
PB:0.31
PE(LYR):0.02

Loading ...

Scinai Immunotherapeutics regains Nasdaq compliance

TIPRANKS
·
Sep 21

ADRs Close Lower; Scinai Immunotherapeutics Ltd. Declines 37%

Dow Jones
·
Sep 16

Scinai Immunotherapeutics refocuses capital on NanoAb platform and CDMO business

TIPRANKS
·
Sep 08

Scinai Swings to FY26 H1 Net Income of USD 1.57 Million; Operating Loss Widens to USD 4.61 Million

Reuters
·
Aug 24

Press Release: Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum

Dow Jones
·
Aug 24

NASDAQ Trade Halt Continues Reason not Available at 07:55 Am

Reuters
·
Aug 21

Press Release: Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

Dow Jones
·
Aug 10

Scinai Q1 FY26 returns to profit at USD 3.58 million; revenue falls to USD 489,000

Reuters
·
Jun 10

Press Release: Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives

Dow Jones
·
Jun 10

Scinai names Eilon Elmalem site head of Yavne CDMO facility

Reuters
·
May 20

Press Release: Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Dow Jones
·
May 20

ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 62%

Dow Jones
·
Apr 25

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

Reuters
·
Apr 24

Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today?

TIPRANKS
·
Apr 24

Scinai Immunotherapeutics announces $2.61M private placement

TIPRANKS
·
Apr 24

Press Release: Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Dow Jones
·
Apr 24

Scinai Immunotherapeutics completes strategic reorganization

TIPRANKS
·
Apr 06

Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Benzinga Earnings
·
Apr 01